Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
2.020
+0.030 (1.51%)
At close: Jun 12, 2026, 4:00 PM EDT
1.967
-0.053 (-2.63%)
After-hours: Jun 12, 2026, 7:56 PM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $48.33 million as of June 12, 2026. Its market cap has decreased by -76.69% in one year.
Market Cap
48.33M
Enterprise Value
40.20M
1-Year Change
-76.69%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $48.33M, a decrease of -68.23%. That is a compound annual growth rate of -46.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 48.33M | -66.02% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edesa Biotech | 50.20M |
| Mereo BioPharma Group | 49.77M |
| Tevogen Bio Holdings | 48.87M |
| Immutep | 48.45M |
| Xilio Therapeutics | 47.80M |
| Radiopharm Theranostics | 47.10M |
| Metagenomi Therapeutics | 46.87M |
| aTyr Pharma | 46.61M |